As an E3 ubiquitin ligase, MDM2 downregulates p53, repressing the p53 regulatory control on transcriptional activity, which ultimately leads to tumour growth.23 Inhibition of the p53/MDM2 interaction has been shown to efficiently rescue p53 from degradation, thus recovering its tumour suppressor activity. Here, MDM2 is linked to neoplasm.